<DOC>
	<DOCNO>NCT00660062</DOCNO>
	<brief_summary>The main purpose study investigate relapse prevent efficacy escitalopram dose range nortriptylin single dose patient treat successfully course electroconvulsive treatment ( ECT ) .</brief_summary>
	<brief_title>Relapse Prevention With Escitalopram Nortriptyline Following Electro-Convulsive Treatment ( DUAG-7 )</brief_title>
	<detailed_description>This study record severity depression relapse patient treat major depressive disorder electroconvulsive treatment ( ECT ) period og 6 month end ECT treatment . Patients randomize four group treat escitalopram 10 mg , 20 mg , 30 mg nortriptylin 100 mg daily dosage . The primary outcome measure relapse secondary outcome measure tolerability . The study multicenter trial within Denmark .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Remission major depressive episode ECT treatment Suicidality ( Hamilton item 3 score 3 ) Symptoms mania ( MAS score 15 ) Duration actual depressive episode 2 year Compulsory measure kind Dementia Severe somatic illness Pregnant lactating subject Known clinical relevant malabsorption . Epilepsia Clinically substantial cognitive deterioration due ECT treatment schizophrenia , schizopreniform schizoaffective disorder Bipolar I , Bipolar II eller Rapid cycling bipolar disorder Abuse alcohol drug Early relapse ( less 2 month ) ECT Inadequate contraception Known intolerance use study medication Myocardial infarction last 6 month Clinical important liver disease Any known disturbance cardiac conduction system , cardiac insufficiency , clinical important cardiac disease Treatment MAOinhibitor Treatment norepinephrine epinephrine Known hyperthyroidism treatment thyroid hormone Known ortostatic hypertension . Glaucoma Known hereditary galactoseintolerance , Lapp Lactase deficiency ) glucose/galactosemalabsorption . Ongoing treatment sympatomimetica efedrine , isoprenaline , physostigmine , dopamine , levodopa , phenylephrine . Ongoing treatment anticholinergica , antiparkinson treatment , antihistamine , atropine , biperiden , Ongoing treatment drug prolongs cardiac QTinterval , quinidine , antihistamine , terfenadine og sotalole Ongoing treatment fluconazole terbinafine Ongoing treatment mefloquin . Known intolerance escitalopram Ongoing treatment serotonergic act substance tramadole , sumatriptane</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Major depression</keyword>
	<keyword>relapse prevention</keyword>
	<keyword>ECT</keyword>
	<keyword>escitalopram</keyword>
	<keyword>nortriptyline</keyword>
</DOC>